Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Invested Capital (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Invested Capital for 4 consecutive years, with $637.0 million as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 24.78% to $637.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $637.0 million through Dec 2025, up 24.78% year-over-year, with the annual reading at $637.0 million for FY2025, 24.78% up from the prior year.
  • Invested Capital for Q4 2025 was $637.0 million at Centessa Pharmaceuticals, up from $411.4 million in the prior quarter.
  • The five-year high for Invested Capital was $637.0 million in Q4 2025, with the low at $215.2 million in Q1 2024.
  • Average Invested Capital over 4 years is $386.6 million, with a median of $392.2 million recorded in 2022.
  • The sharpest move saw Invested Capital crashed 38.92% in 2023, then skyrocketed 130.29% in 2025.
  • Over 4 years, Invested Capital stood at $336.2 million in 2022, then fell by 29.72% to $236.2 million in 2023, then soared by 116.08% to $510.5 million in 2024, then increased by 24.78% to $637.0 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $637.0 million, $411.4 million, and $454.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.